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Frequency analysis of the electrocardiographic RR interval is a common method of
quantifying autonomic outflow by measuring the beat-to-beat modulation of the heart
(heart rate variability; HRV). This review identifies a series of problems with the methods
of doing so—the interpretation of low-frequency spectral power, the multiple use of
equivalent normalized low frequency (LFnu), high frequency (HFnu) and ratio (LF/HF)
terms, and the lack of control over extraneous variables, and reviews research in the
calendar year 2012 to determine their prevalence and severity. Results support the
mathematical equivalency of ratio units across studies, a reliance on those variables
to explain autonomic outflow, and insufficient control of critical experimental variables.
Research measurement of HRV has a substantial need for general methodological
improvement.
Keywords: heart rate variability, autonomic nervous system, sympatho-vagal balance, sympathetic nervous
system, parasympathetic nervous system
INTRODUCTION
Heart rate variability (HRV), the fluctuation of instantaneous
heart period over time, is a correlate of cardiac autonomic reg-
ulation. HRV techniques have been applied in a broad range of
contexts—they have been used to predict mortality after myocar-
dial infarction (Buccelletti et al., 2009), as a correlate of stress
(Berntson and Cacioppo, 2007) and psychopathology, to stratify
attention (Mulder and Mulder, 1981), and have been incorpo-
rated into biobehavioral models of self-regulation (Porges, 1995;
Thayer and Lane, 2000). The idea that reliable measurement of
autonomic state may be obtained cheaply and non-invasively is
obviously appealing. Figure 1 illustrates a growing interest in
HRV methods over time, a trend which seem likely to continue
given the increasing access to heart rate data through recent
technological advances—heart rate has recently been accurately
calculated via smartphone (Heathers, 2013), microwave (Suzuki
et al., 2008) and induction-powered indwelling device (Riistama
et al., 2007).
Short recordings of HRV (i.e., less than 1 h) typically show two
primary patterns of oscillation which are separated into frequency
bands from ≈7 to 25 s (0.04–0.15Hz; low frequency, or LF) and
2.5 to ≈7 s (0.15–0.4Hz; high frequency, or HF)—lower frequen-
cies than LF are generally not meaningful over the short term. LF
and HF frequency bands are widely used to quantify parasympa-
thetic and sympathetic regulation (Akselrod et al., 1981) and their
interaction (Malliani et al., 1991).
As ease of access to HRV increases, establishing and maintain-
ing correct methodology is important—redundant methodology
may delay treatment, obscure valuable underlying effects, provoke
Type I or II errors, and most importantly, potentially delegitimize
both alternative useful results and the utility of HRV in general.
However, the internal and external consistency of the methods
used have received comparatively less research interest than the
understanding of the autonomic, cardiac and circulatory which
creates those methods (Billman, 2011).
Thus, this paper presents a focused review of HRV methodol-
ogy in the frequency domain which serves two purposes. Firstly,
to raise several inter-connected points concerning the collec-
tion, interpretation and interrelationship of frequency-domain
HRV variables, and external factors which may influence their
recording. While there are many unsettled questions concern-
ing meaning and calculation frequency domain HRV, the points
raised here are generally not in dispute—they are either derived
from a strong base of evidence, or are defined mathematically.
Secondly, to formally outline the awareness of these method-
ological points with reference to a large convenience sample of
work using HRV methods. This sample is drawn from the most
recent complete calendar year (2012) at the time of writing.
THE INTERPRETATION OF LF POWER
All measures of HRV are necessarily complex as heart period over
time is variously affected by multiple autonomic outflows, the
modulation of those outflows at the sinoatrial node, their pace-
maker response and competition, and the dynamic regulation of
the vasculature, as well as endocrine, endothelial and mechan-
ical factors. These interactions are further complicated by the
realization that the individual mechanisms which may influence
heart period are themselves incompletely understood. Examples
include the source of cardiorespiratory coupling via either a
central oscillator or the baroreflex (Eckberg, 2009; Karemaker,
2009), the mechanism behind periodic changes in blood pressure
(Julien, 2006), the intrinsic meaning or function of respiratory
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FIGURE 1 | Published research with “heart rate variability” in the title.
At the time of writing, the value for 2013 was extrapolated from the
publications Jan 1st through April 30th.
sinus arrhythmia (Hayano et al., 1996; Tzeng et al., 2009; Ben-Tal
et al., 2012; Elstad, 2012).
Irrespective of this, the power spectral density of high fre-
quency HRV is strongly associated with cardiovagal activity
(Akselrod et al., 1981; Kamath and Fallen, 1993; Malik, 1996).
Respiratory variation observed in heart period is linearly related
to parasympathetic control of heart rate (Katona and Jih, 1975),
and its modulation forms the theoretical center of most HRV
analysis. However, it should be noted that HF HRV is not abol-
ished by vagotomy (Tzeng et al., 2005, 2007), and shows a
complex and only somewhat dose-dependent relationship with
muscarinic blockade (Picard et al., 2009).
Alternatively, the debate over the characterization, meaning
and utility of LF HRV is ongoing issue (Akselrod et al., 1981;
Porges and Byrne, 1992; Hopf et al., 1995; Introna et al., 1995;
Sleight et al., 1995; Eckberg, 1997; Grasso et al., 1997; Malliani
et al., 1998; Sleight and Bernardi, 1998; Houle and Billman, 1999;
Notarius et al., 1999; Notarius and Floras, 2001; Elghozi and
Julien, 2007; Billman, 2011, 2013; Goldstein et al., 2011; Pagani
et al., 2012; Reyes del Paso et al., 2013).
To fully describe the physiology involved above is beyond the
scope of this review. Within the present context, we may con-
fine ourselves to addressing one common claim about frequency
analysis—the involvement of the SNS in vasomotor control
(Julien, 2006), and the strong relationship between the barore-
flex and LF power (Goldstein et al., 2011) has occasionally been
extrapolated to the position that LF power is proportional to car-
diac sympathetic nerve activity. The direct evidence against this
claim is strong even if confined to just non-invasive or minimally
invasive studies in humans.
For instance, beta-adrenergic antagonists have shown diver-
gent effects on LF power. Jokkel et al. (1995), for instance,
report an approximate doubling of LF power in response to
total beta-adrenergic blockade with propanolol (a non-selective
β-blocker). A modest increase in LF power (Chiladakis et al.,
2004) or no difference to baseline (Taylor et al., 1998) have been
reported subsequent to treatment with atenolol (a β1-antagonist).
Likewise, cardiac 6-[18F] fluorodopamine imaging in humans
(Goldstein et al., 1990, 1993), which radiolabels catecholamine
storage vesicles, has repeatedly shown no relationship between
radioactivity subsequent to cardiac sympathetic activity and
LF-HRV power (Alvarenga et al., 2006;Moak et al., 2007; Rahman
et al., 2011). Likewise, there are dissociations between other mea-
surements of SNS via impedance cardiograph (Goedhart et al.,
2008), salivary alpha-amylase (Nater et al., 2007; Kobayashi
et al., 2012), circulating epinephrine/norepinephrine (Sloan
et al., 1996), and muscle sympathetic nerve activity (Grassi and
Esler, 1999). This evidence has been recently covered at length
(Goldstein et al., 2011; Reyes del Paso et al., 2013).
The connection between LF power and sympathetic activity,
while frequently cited as representative of (Pagani et al., 1984,
1986), is a misrepresentation of the initial claim that normalized
LF power is representative of relative sympathetic power as a mea-
sure of sympathovagal balance. This, and related theory, is dealt
with below.
THE LF/HF RATIO
The ratio of low-frequency power to high-frequency power
(LF/HF ratio), as popularized by (Pagani et al., 1984, 1986), is
commonly used as a measure of sympathovagal balance—the
putative balance between the mutually opposing branches of the
autonomic nervous system. While widely used, this approach
has been criticized on a number of grounds. The disconnection
between this understanding of short-term spectral power within
the heart series and the known physiology related to that power
(Eckberg, 1997; Goldstein et al., 2011; Billman, 2013), and the
response to those criticisms (Malliani et al., 1998; Pagani et al.,
2012), have been covered in detail. As above, much of this is a
natural extension of the argument that the numerator (i.e., LF
power) reflects sympathetic outflow poorly, if at all.
From a methodological perspective, however, it is most con-
cerning that there may be no mathematical basis on which to
compare LF and HF power. Values of HRV are typically internally
consistent, in that changes within a frequency band on individ-
ual sequential measurements may be directional or proportional.
That is to say, it is meaningful that an individual under acute stress
experiences a reduction in HF power from baseline, and that
additive stress provokes additive change. However, those changes
have less bearing on other measured quantities (i.e., a loss of HF
power is compared to a loss of LF power; a loss of HF power
between individuals, etc.). This is subsequent to considerations
such that (a) fluctuations in HRV should more correctly be con-
sidered fluctuations in the modulation of autonomic tone, not a
change in autonomic outflow (e.g., Katona et al., 1977), (b) the
properties of interaction and competition between muscarinic
and adrenergic outflow at the sinoatrial node are both non-linear
(e.g., Levy, 1984) and mediated by neuropeptide co-transmitters
(e.g., Revington and McCloskey, 1990), and c) changes in both
low- and high- frequency power are mediated by both SNS and
PNS (e.g., Taylor et al., 2001). This is often expressed simply
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by characterizing HRV as a qualitative, not quantitative, variable
(Notarius and Floras, 2001; Billman, 2011).
However, the possibility of measuring sympathovagal balance
in the manner above has been repeatedly classed as heuristic
(Malliani et al., 1998; Sleight and Bernardi, 1998; Malliani, 2005).
This position has a great deal of merit, as it is inevitable that
complex or poorly understood phenomena will be demonstrably
related to other dependent or independent variables in advance of
our ability to explain why this is so. In other words, a metric may
be useful well before it appears meaningful. One argument related
to the above is the clear interrelationship during graded ortho-
static tilt between (1) tilt angle, (2) sympathetic outflow, and (3)
LF/HF ratio, the conclusion being that as all of these positively
covary, then LF/HF ratio well describes, and is capable of predict-
ing tilt angle (Montano et al., 1994). This may be the case, but
only indicates an association between these factors, rather than a
reason for their association.
Orthostasis provides an interesting comparative example.
Figure 2 graphs mean pre-ejection period (PEP) against the angle
of graded tilt with an overlaid quadratic regression (assuming that
the relationship between cardiovascular response to tilt vs. angle
is curvilinear). In this situation, the heuristic value of adjusted or
unadjusted PEP is substantial, perhaps equivalent of some reports
of spectral power (Bahjaoui-Bouhaddi et al., 2000), even without
considering the individual regressions.
It seems very likely that predictions made in the manner of
Malliani et al. (1997), where normalized units were successfully
employed in a model to delineate posture, would be successful
with PEP. Thus, as the following are clearly demonstrated:
(1) there is a predictable, positive relationship between PEP and
positive tilt
(2) this relationship parallels an established positive relation-
ship between SNS outflow and positive tilt (e.g., Chosy and
Graham, 1965; Iwase et al., 1987)
FIGURE 2 | The curvilinear relationship between pre-ejection period
(PEP) and tilt angle during orthstatic stress. Data from Chan et al. (2007)
(1) and Stafford et al. (1970) (2).
. . . we may draw a heuristic conclusion:
(3) PEP is positively related to sympathetic outflow.
However, the normal relationship between PEP and SNS out-
flow is precisely the opposite. Sympathetic activity, as measured
by circulating catecholamines (Chosy and Graham, 1965) or by
MSNA (Iwase et al., 1987), increases reliably during orthostatic
tilt. In other contexts, this might well accompany a decrease in
PEP (Newlin and Levenson, 1979). However, our model here fails
to account for the effects of preload—the initial stretching of the
myocardium due to passive factors prior to the cardiac cycle—
which increases proportionally with tilt angle independently of
sympathetic drive (Stafford et al., 1970). Thus, a heuristic vari-
able formed between two robust associations may be precisely
predictive but ultimately misleading. This is precisely the criti-
cism leveled by Grassi and Esler (1999); that LF/HF ratio fails to
describe SNS outflow outside of the demonstration provided by
changes in orthostasis.
Finally, the source of LF power is well characterized—LF power
generally reflects the activity of the baroreflex in response to vaso-
motor tone. This is broadly accepted consequential to the classical
demonstrations of the close correspondence between blood pres-
sure waves and sympathetic modulation (Guyton and Harris,
1951), which are reflected in the heart period by the compen-
sation of the baroreflex. This interpretation is not in dispute; a
comprehensive summary is given in Berntson et al. (1997).
THE REDUNDANCY OF NORMALIZED UNITS AND LF/HF RATIO
Normalized HRV values (LFnu, HFnu) are calculated from the
raw values of either short-term frequency band (LF or HF)
divided by the total spectral power (typically LF + HF), with
the value of this typically expressed as a percentage or decimal.
These variables have a long history (e.g., Lombardi et al., 1987)
in quantifying HRV, and have been used to quantify propor-
tional sympathetic and parasympathetic activity respectively (e.g.,
Pagani et al., 1986). They are of particular interest in reviewing
the available literature as they provide a degree of interpretability
between studies, as proportional change between defined fre-
quency bands can be seen as roughly equivalent regardless of
the spectral method used. Unlike raw power, this allows direct
comparison between frequency and autoregressive methods for
calculating spectral power, between spectral power expressed as
ms2 or bpm2, and between different algorithms for calculation,
windowing methods, time periods, etc. These differences often
result in baseline spectral values which are multiple orders of
magnitude apart between studies (Sandercock, 2007).
However, the typical use of normalized units presents a series
of significant redundancies. Firstly, LFnu and HFnu are trivially
equivalent, as LFnu = 1-HFnu. This implies that calculations
cannot be duplicated, as LFnu calculations are perfectly linearly
related (i.e., computationally identical) to HFnu (Chemla et al.,
2005). Reporting both values provides no additional information
over reporting one, and change in one is identical to change in
the other. In this manner, it is necessarily incorrect to refer to
HFnu and LFnu as separate concepts. Instead, this model must
describe a single autonomic continuum along which individual
points represent the admixture of low and high frequency power.
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Furthermore, reporting calculations where only one normalized
value is significant should be considered inconsistent.
There are exceptions to the above. Firstly, when normal-
ized values are calculated from an expanded power spectrum;
occasionally, Very Low Frequency (VLF; 0.003–0.04Hz) may be
included in the denominator of normalized units (i.e., LFnu =
LF/VLF + LF + HF), likewise power about the HF cutoff
(i.e., >0.4Hz), or the total power of the observed spectrum (TP;
0–0.5Hz) may be used as the denominator (i.e., LFnu = LF/TP;
this is sometimes called LF%). However, in short recordings, the
inclusion of these longer timescales is a significant problem as the
contribution from very low frequencies is undersampled in the
manner described below, and the Nyquist criterion prevents any
meaningful contribution at frequencies higher than HF.
Secondly, when the autoregressive method is used to quantify
spectral bands, often, the individual components identified
for LF and HF bands sum to less than the measure of “total
power”—the additive model minus the component at VLF. In
this case, LFnu + HFnu will be less than 1, but most likely very
close to it. As far as I am aware, there is no evidence to indicate
that this establishes LFnu and HFnu as separate theoretical
entities rather than measurement error. If the autoregressive
model is a poor fit for the available data, then LFnu + HFnu may
be significantly less than 1.
In addition, it is trivial to transform the LF/HF ratio as directly
proportional to a normalized value of either spectral band (Burr,
2007):
If
LF
HF
= α,
i.e. HF = LF
α
then,
LFnu = LF
LF + HF
= LF
LF + LF
α
= 1
1 + 1
α
i.e. LFnu = 1
1 + ( LFHF
)−1
and HFnu = 1
1 + ( LFHF
)
Graphically, the function above is shown in Figure 3A—it is
monotonically increasing at all positive non-zero values, non-
linear, and well approximated by logarithmic regression over
a typically observed range (r2 > 0.99). As the distribution of
the LF/HF ratio is often positively skewed, it is frequently log-
transformed to meet criteria of normality (e.g., Kobayashi et al.,
2012). In this case, the non-linear relationship becomes sig-
nificantly attenuated and very closely approximates linearity
(Figure 3B)—thus a linear regression has an identical coefficient,
constant term and r2-value.
In this manner, any given value of LFnu or HFnu has a
directly equivalent LF/HF value. It should be emphasized that
this is not a conceptual similarity but an equivalence at the level
of definition—for example, an LF/HF ratio of 0.6 is precisely
equivalent to LFnu = 37.5% or HFnu = 62.5%. Consequently,
individual normalized values contain no more information than
individual LF/HF ratio values, and on this basis it is unclear
how “sympathetic balance” (LFnu) is mathematically different to
“parasympathetic modulation” (HFnu) or how either is concep-
tually different to “sympathovagal balance” (LF/HF).
Similarly, due to the non-normal distribution of typical
data, HRV variables are occasionally presented as median and
interquartile range. As rank order is preserved in a monotonic
increasing relationship, medians and inter-quartile values should
remain direct transformations of each other, and statistical calcu-
lations on rank order should be identical between normalized and
ratio values; a full description of this and other redundancies can
be seen in Burr (2007).
However, due to the moderate non-linearity, mean (LF/HF)
is not identical to mean (LFnu). This relationship is explored in
FIGURE 3 | The direct equivalence of normalized to ratio values with logarithmic regression (A), and of normalized to log-ratio values with linear
regression (B). Values drawn from LFnu 0.2 to 0.8, n = 25.
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Figure 4, where LFnu and LF/HF values from realistic artificial
samples reveal a convergence toward the central value of LFnu
with larger sample size, and a consistent predictive value between
means. Thus, it is likely that statistical comparisons under stan-
dard parametric assumptions for LF nu and LF/HF would be
similar without being identical.
FIGURE 4 | A comparison of LFnu vs. LF/HF sample means, with (A)
n = 15, (B) n = 30, (C) n = 100. Points are means derived from
approximately typical pseudorandom (Mersenne Twister) normally
distributed values of LF ms2 (mean = 600, SD = 200) and HF ms2
(mean = 800, SD = 200). The values are distributed near the point of mean
equivalence, LFnu = 0.429. r2-values range from 0.833 to 0.902.
INTERPRETING NORMALIZED UNITS IN THE ABSENCE OF RAW POWER
Normalized units, which report frequency power proportional to
the total observed power, possess an additional problem—that
several different patterns of change in individual spectral bands
may result in identical changes in proportion. This is illustrated in
Figure 5, where a hypothetical participant with a baseline LFnu=
0.33 increases to LFnu= 0.5 after experimental intervention. This
change in normalized units therefore represents not one possi-
ble change, but a continuum of possible changes which variously
encompass (1) an increase, decrease or no change in (2) either
total power, raw LF or raw HF power. Any point on the line of
identity described in Figure 5 fulfills the criteria of LFnu = 0.5,
but the individual points represent entirely different outcomes
(Billman, 2013).
In other words, the reporting of HRV solely as a propor-
tion directly obscures the underlying interpretation. It is precisely
this form of interpretability which the seminal Task Force paper
(Malik, 1996) sought to preserve within normalized values by rec-
ommending that research should always report both normalized
and raw values for clarity.
This is not merely a hypothetical scenario, and one of our
recent papers illustrates this clearly (Krygier et al., 2013). In
this study, comparisons of HRV metrics are drawn from a sam-
ple of meditators at rest and during Vipassana meditation, and
both before and after an intense intervention—around 100 h
of intensive training over 10 days. While the overall interac-
tion was not significant, an intriguing and significant increase in
HFnu was observed, as reported in previous research on simi-
lar forms of meditation (e.g., Sarang and Telles, 2006; Wu and
Lo, 2008; An et al., 2010). A naïve characterization might be that
a beneficial change representing an “increase in vagal tone” or
a “favourable autonomic balance” was introduced by meditative
FIGURE 5 | The outcome of a hypothetical experiential effect—a
participant with LFnu = 0.33 (LF ms2 = 500, HF ms2 = 1000) increases
to LFnu = 0.5, which is defined by any point on the line of identity (i.e.,
LF ms2 = HF ms2). The arrows and operations on the line designate where
values may be smaller, equal to, or greater for the corresponding spectral
regions (LF, low frequency; HF, high frequency; and TP, total power).
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training, but follow-up analyses revealed that normalized change
was specifically mediated by (a) a profound increase in HRV at
breathing frequency during meditation in untrained participants,
and (b) a profound decrease in HRV at Mayer wave frequency
during meditation when trained (Figure 6).
These changes precisely mirror the subjective reports of how
meditative practice proceeds. Naïve practitioners of Vipassana,
instructed to observe the breathing cycle rather than alter it,
invariably “over-breathe,” which typically corresponds to an
increased tidal volume and reduced respiratory rate. Within the
lower portion of the HF spectra, this increases observedHF power
(Hirsch and Bishop, 1981; Brown et al., 1993). However, this
problem is mastered within a few days as participants practice the
ability to passively observe normal respiratory cycles.
The above is a single unreplicated finding, and due to the
nature of the task, breathing could not be consciously controlled
(a potential confound, as breath has its own relationship to atten-
tion; see Vlemincx et al., 2012). Thus, while the above explanation
is speculative, two points remain regardless: (1) the reference to
individual frequency bands has greater explanatory power than
the original naïve interpretation, especially considering changes
in respiratory parameters, mood, attention, etc. are reliably pre-
dicted by spectral power in individual frequencies, and (2) the
changes described within individual frequency bands may be
entirely inconsistent with, and obscured by, the reporting of lone
normalized HRV values.
TIME RESOLUTION OF LF POWER
While an RR series does not consist entirely of cyclical processes
(Peng et al., 1995), frequency analysis approximates the action of
autonomic outflow to the heart by quantifying cyclical informa-
tion present. In doing so, the number of times a cyclical frequency
can be observed during an electrocardiographic recording varies
linearly with the length of the recording, and inversely with the
period of the frequency.
Consequently, HF HRV may be successfully recorded over
periods of time as short as 60 s (Malik, 1996) as this gives adequate
resolution to cycles within the heart period driven by respira-
tory sinus arrhythmia, typically around 0.25Hz at rest. LF HRV
requires a longer period in order for the spectral information to
be reliably present. In short recordings, these frequencies may be
insufficiently sampled—a signal at 0.04Hz (i.e., with a period of
25 s) is observed 2.4 times per minute.
A heuristic rule which has been occasionally stated requires
the sampling period to contain 10 complete cycles of the lowest
observed frequency in order for the underlying information to
be successfully approximated (Malik, 1996; Berntson et al., 1997)
but there appears to be no analytical exposition of this. This has
loosely translated into an accepted standard of a 5min recording
to measure short-term HRV, as a 5min recording by this defi-
nition can resolve frequencies down to 0.033Hz. Consequently,
power from the LF spectrum down to 0.04Hz is necessarily
included in both normalized and LF/HF ratio calculations of
HRV. Thus, both measurements should be taken over a minimum
of 5min.
EXTRANEOUS VARIABLES TO RECORDING BASELINE HEART PERIOD
Studies which measure variables that may be broadly affected
by incidental day-to-day factors are usually carefully controlled.
In human populations, research is often conducted specific to
age group, experimental environment, time of day, medication
status, environmental stimulants (i.e., caffeine or other methylx-
anthines), and so on. In longer studies or those requiring stren-
uous activity, standardized food and drink is provided. Studies
in HRV are especially subject to these concerns—due to the auto-
nomic innervation of the viscera, there are several instances where
FIGURE 6 | Adapted from Krygier et al. (2013), Figure 1, with permission. The devolution of the normalized results (top panel) into raw power (bottom
panel) reveals two specific effects inconsistent with the overall interpretation of an alteration in autonomic balance. ∗p < 0.05.
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artifacts to short-term HRV measurement at rest may reliably
arise from demographic variables, and the normal activities of
daily living. Of course, controlling daily activity is not possible
or even desirable in some patient groups, especially if long term
monitoring is required (i.e., if measured over 24 h) but in labo-
ratory or naturalistic experiments, it is ideal to observe potential
changes in autonomic activity with as few confounding variables
present as possible.
These variables are occasionally recognized; most research, for
instance, is aware that HRV declines with age (O’Brien et al.,
1986), is broadly affected by cardiovascular, vasoactive and psy-
chotropic medication (e.g., beta-blockers; Sandrone et al., 1994),
and is affected by both circadian rhythm (e.g., Massin et al., 2000)
and wakefulness (Walker et al., 2009). Less frequently recognized
is the finding that the autonomic innervation of the viscera means
the consequences of feeding (i.e., the acute consumption of food
and water, gastric distension and bladder filling) directly affect
HRV.
Of these, the most attention has been paid to water con-
sumption (May and Jordan, 2011) subsequent to the finding that
patients with severe hypotension due to autonomic failure derived
a significant reduction in symptoms from drinking water, and
this subjective improvement was observed parallel to substan-
tial increases in blood pressure (Jordan et al., 2000). A similar
effect can be observed when the baroreflex loop is opened in
sinoaortically denervated mice (McHugh et al., 2010).
In normal participants, the same presumed pressor effect takes
place, and can be observed in muscle sympathetic outflow (Scott
et al., 2001), but changes in blood pressure are immediately
buffered by the efferent vagal baroreflex, and the immediate con-
sequence is a moderate to large compensatory increase in heart
period and HF-HRV. Healthy participants approximately dou-
ble baseline HF-HRV, while the effects on HR are significant
within 10min after ingestion, peak at around 15–20min and
return to baseline by 45min (Routledge et al., 2002). Recent work
(Mendonca et al., 2013) has suggested that these effects only
become negligent at VO2 maximum.
Eating and subsequent digestion have autonomic conse-
quences which appear to be mediated both by gastric distention
(Rossi et al., 1998) and by exposure to food-related stimuli
(Nederkoorn et al., 2000). Mechanical and electrical stimuli to
the stomach are both powerful hypotensive stimuli (Pozo et al.,
1985), and this effect is abolished by vagotomy (Liu et al., 2004).
In addition, the digestive process provokes vagal withdrawal as
measured by HRV for at least 60min after a meal (Lu et al.,
1999), and increases sympathetic outflow to the skeletal muscles
but not the heart (Fagius and Berne, 1994; Cox et al., 1995). Due
to the relationship between the thermic effect of food and sympa-
thetic outflow, this response is heavily affected by macronutrient
composition (Welle et al., 1981; Schwartz et al., 1985).
Finally, bladder distension has been observed to provoke a
robust series of pressor-mediated responses in humans (Fagius
and Karhuvaara, 1989), where bladder distention predicts an
increase in muscle sympathetic nerve outflow and blood pres-
sure. Ben-Dror et al. (2012) subsequently delineated a linear
rise in lnLF power with acute bladder filling in healthy con-
trols drinking water. While this may have been confounded with
the osmopressor effect (as above), a similar effect was observed
using filling cystometry (i.e., causing bladder distension without
drinking; Mehnert et al., 2009).
REVIEW PARAMETERS
In order to confirm both the nature and the extent of the prob-
lems outlined above, a substantial body of work is drawn from
the recent HRV literature (i.e., from 2012). This allows the pos-
sibility of (a) sufficiently characterizing HRV research as it is
presently performed with reference to the methodological issues
raised, (b) confirming the presence and relevance of the mathe-
matical relationships defined above, and (c) observing the extent
of experimental controls currently employed.
METHODS
A non-systematic review was conducted: Google Scholar and
PubMed databases were searched using the terms “heart rate vari-
ability” or “HRV” through either the title or abstract, with a date
restriction of 01/01/12 through 31/12/12. Full text articles were
obtained.
REVIEW PROCESS
Non-English language journals, 24 h studies (title/abstract:
“Holter,” “24 hr”), animal (title/abstract: “mouse,” “rat,” “dog,”
etc.), developmental (title/abstract: “neonatal,” “infant,” “child,”
etc.), geriatric (title/abstract: “elderly,” “geriatric,” etc.), and con-
ference abstract, qualitative or discussion papers (title/abstract:
“editorial,” “conference,” “review,” etc.) were excluded, as were
papers which were formally published in 2011 or 2013 (n = 293).
The remaining papers (n = 573) were superficially reviewed to set
initial criteria for inclusion.
SELECTION CRITERIA
Age
Pre-natal, infant, child and youth (mean age <18 years) samples,
and elderly/geriatric samples (mean age> 65) were excluded.
Time period
Consistent recording for more than 1 h was not considered
short-term and excluded. 24 h or Holter monitor studies were
included only if a short-term period was additionally analyzed
and reported to the daily record.
Descriptive work
Reviews, meta-analyses, position papers or commentaries, corre-
spondence, etc. were excluded if descriptive of HRV phenomena
instead of primary research, and included if they reported data
from novel primary research.
Breathing
Paced breathing at speeds above 0.15Hz was included. Breathing
protocols slower than 0.15Hz likely to affect the fundamental
distribution of spectral power were excluded.
Healthy baseline condition
If plural baseline conditions were included within-subjects over
one or multiple sessions, the first criteria reported—either by
time, or if unclear, by listed order—was considered the baseline.
www.frontiersin.org May 2014 | Volume 5 | Article 177 | 7
Heathers Methodology in HRV
If plural conditions were averaged to make a global value, this was
considered equal to the total recorded time. If a baseline included
plural subsequent measurement periods, i.e., two recordings of
3min separated by task, then the first was used. Subsequent peri-
ods (i.e., “first 5mins, second 5mins”) were recorded as a single
value if given otherwise the first period was used. Studies com-
bining the averages of multiple time periods (i.e., the average
of spectral values from two 3min periods) were not recorded.
Baselines immediately before surgery requiring general anes-
thesia were not considered resting, due to anticipatory anxiety.
Multiple healthy groups from the same study were included if (a)
listed separately at all points, and (b) were taken from baselines
administered before random assignment into groups, or after
assignment in benign circumstances. If sub-clinical groups from
healthy populations were defined (i.e., “high normal” anxiety vs.
“low normal” anxiety) then the low pathology group was used.
Unless specifically stated as standing or supine, it was assumed
that participants or patients were seated.
RECORDED INFORMATION
LF power
The genesis of LF power provided was classified as being either
(a) sympathetically mediated, (b) resulting from “both parasym-
pathetic and sympathetic modulation,” (c) representing the gain
of the baroreflex, or (d) other (parasympathetically mediated/not
stated). Studies specifically measuring the LF response to graded
tilt or postural change were taken as implying a relationship
between LF and baroreflex outflow, as this is an orthostatic
manipulation. If the basis of LF was derived from a reference
without an explicit statement of what LF power was to represent,
the interpretation within the reference was used according to the
above criteria.
CONTROL OF EXTRANEOUS VARIABLES
Circadian
Circadian factors were considered controlled if both between and
within subject comparisons were identical within a 24hr period,
and confined to an hour or a time window of up to 4 h (i.e., “9 am
to 1 pm” or “beginning in the early morning”).
Illness/Medication
Work addressing serious, debilitating, psychiatric or other
chronic illness, or any illness whose primary etiology was car-
diovascular or circulatory, was included only if a control group
was available, as baseline HRV level or collection/analysis tech-
nique may be affected. Non-life threatening illness treatable with
standard pharmacotherapy (such as asthma) or post-treatment
groups which did not require major pharmacotherapy or surgery
(e.g., recovered phobics) were included. The exclusion or sta-
tistical control of any medication apart from the contraceptive
pill or unscheduled analgesics (e.g., Paracetamol, Ibuprofen) was
considered controlled.
Food/Water
Meals were regarded as controlled either if participants were
recorded during a fasted state, or if a standard meal was pro-
vided or prescribed for study inclusion, likewise water. A fasted
state was assumed for participants measured at baseline before
tilt-table testing. Water provided ad libitum was not considered
controlled.
Bladder
Bladder emptying was only recorded if it was explicitly stated, as
no pre-surgical population was included.
Content
With the exclusion criteria as above, the review proceeded
pseudo-randomly (i.e., sequentially in alphabetical order by the
surname of the first author) until 100 samples were recorded.
ANALYSIS
Comparisons between values were modeled respectively
as the regressions HFnu = a/(b + c.(LF/HF)), LFnu =
a/(b + c.(HF/LF)); all used the least-squares method and
assumed initial conditions of any nominal constant = 1. The
relationship between LFnu and HFnu was modeled by linear
regression.
Relative standard errors (RSE; the standard error of the mean
divided by the mean) were taken as measures of adjusted reliabil-
ity for individual studies, and calculated from LF/HF ratios which
were given in milliseconds squared, LFnu and HFnu values.
All calculations were performed in GraphPad Prism 5.
RESULTS
From n = 378 papers, n = 97 papers were accepted (n = 3 stud-
ies contained multiple baseline groups which met inclusion crite-
ria), to give a total of n = 100 records of HRV at baseline. The list
of these papers is included as supplementary material. If data was
provided, participant age, sample size, HFnu mean and standard
deviation (calculated from SEM if necessary), LFnu (likewise), or
median and inter-quartile range were recorded separately. LF%
and HF% were not recorded, as the inclusion of VLF power
within short term calculations is problematic. All forms of spec-
tral analysis (i.e., autoregressive method, FFT/DFT, Lomb-Scargle
Periodogram, wavelet analysis etc.) were included as equivalent
spectral analytical methods, as normalized units and/or LF/HF
ratio were the recorded variables. The characterization of the
acceptance/rejection criteria and use of spectral power is shown
in Tables 1, 2.
Extraneous controls varied substantially between measures: of
the 97 separate studies accepted, 81% controlled for medication
or health status, 76% for nicotine use, 58% for time of recording,
45% controlled for food intake, 23% controlled for water intake,
and 4% for micturition. Of the above n = 97 studies, 91 (94%)
analyzed some version of LF power, and 74 (76%) reported at
least one normalized or ratio unit measure. 50 papers specifically
reported the LF/HF ratio: 13/50 (26%) reported log-corrected
units and 37/50 (74%) reported uncorrected units.
The time periods used forHRV recording were primarily 5min
(n = 40; 41%), or 10min (n = 20; 21%). Recording times under
5min were uncommon (n = 13; 13%), with n = 10 (10%) of
these using a measure of LF power.
Remaining figures are descriptive of the parameters of review;
Figure 7 describes the primary interpretation given to ratio or
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Table 1 | Inclusion and exclusion criteria for reviewed studies.
375 Reviewed
278 Excluded
26 24h or Holter monitor study
6 Animal
1 Duplicate record in database
11 Elderly, geriatric, or palliative sample
7 Elite or high level athletes
86 Exclusive to patient population
1 Incorrect calendar year (i.e., published 2013)
32 Infant, child or teenage sample
50 Letter, review, commentary, etc.
23 No resting baseline given
17 Non-linear, non-standard, etc. measures
13 Time domain measures only
5 Unavailable at the time of review
97 Included
97 Met criteria
3 Multiple or duplicate usable records
Table 2 | Reporting of raw vs. adjusted values, single vs. multiple
normalized or ratio units.
Reported No raw
raw values values
Single nu/Ratio unit 26 4 30
Multiple nu/Ratio units 26 18 44
52 22 n = 74
normalized power. The number of points available for each indi-
vidual comparison below is noted separately per figure. Figure 8
shows the means and relevant interquartile values assumed to be
precisely equivalent due to equal rank order with the inverse-
term regression relating LF/HF and nu units overlaid. Figure 9
describes the sum and interrelationship of normalized values
assumed to be precisely equal to unity. The relationship between
mean normalized units and mean LF/HF ratio is shown in
Figure 10, and their precision is shown in Figure 11.
DISCUSSION
Overall, the use of frequency analysis over short-term heart rate
recordings to characterize autonomic state or sympathovagal bal-
ance is problematic. Relevant research frequently truncates or fails
to explain the source of HRV power. Commonly co-investigated
variables are reported as separate concepts, but are mathemati-
cally redundant as predicted. This redundancy is precise between
individual values andmoderate between groupmeans. Time peri-
ods employed for recording are generally sufficient. Confounding
variables which have the potential to substantially alter between-
and within-subject variance are infrequently controlled.
OVERALL PRECISION AND EXPERIMENTAL CONTROL
The control of extraneous factors affecting recording in par-
ticipants is perhaps the most problematic of the results here,
because it may irreparably affect the veracity of between-subjects
FIGURE 7 | Venn diagram for the various explanations given as the
source of LF power. SNS, sympathetic nervous system; BAL, a balance of
parasympathetic and sympathetic influences; BAR, the activity of the
baroreflex; PNS, parasympathetic nervous system.
experimental models. Of course, depending on the circum-
stances, it may not be possible or even desirable to control
all the listed variables—for instance, patient populations must
remain on medication, opportunistic recording at any time
of day is necessary to observe an episodic phenomenon, etc.
However, the fact remains that circadian rhythm, medication,
health status, food, water and bladder filling all potentially pos-
sess the ability to modify the variance of a normative group,
even if only problematic in a minority of participants. Some
of these external factors (medication, health status, and nico-
tine use) are well controlled, but a minority of work con-
trolled for gastric or bladder filling. The amount that this
affects a normative sample of HRV needs to be determined
experimentally.
For experimentation within subjects, the situation is a lot less
clear. Obviously, if within-subject measurement involves an inter-
vention over multiple recording periods in time, the potential
contamination presents precisely as it would between subjects.
However, if a task effect is being observed in sequential record-
ing periods during the same experiment, the problem may be
substantially reduced. That is, in the presence of a strong arti-
fact, the absolute or proportional change in HRV in response to
a drug, task, intervention etc. may occur reliably but simply from
an altered baseline.
Say, for instance, that gastric activity subsequent to feed-
ing increases LF spectral power in an experimental participant
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FIGURE 8 | The relationshipofpreciselyequivalentvalues, i.e.,medianand
interquartile range (IQR) between LFnu (A) or HFnu (B) and LF/HF ratio.
Regression estimates: (A) a = 1.00, b = 0.94, c = 1.06, r2 = 0.985, n = 7; (B)
a = 1.00,b = 0.98, c = 1.05, r2 = 0.981,n = 7.Valueswereuncommonas few
studies reported both normalized and LF/HF ratio values in median/IQR format.
The dashed line represents the mathematical identity as previously defined.
FIGURE 9 | The cumulative sums of the normalized components
when (A) both were specified, and (B) their interrelationship
(slope = −1.003± 0.1103, r2 = 0.761, n = 20). The dashed line in (B)
represents the mathematical identity as previously defined. Points marked
as diamonds are LFnu + HFnu <90%, and marked where relevant on
Figure 10.
who is then subjected to social stress, which is also expected to
increase LF power. If that power rises to a proportional level,
i.e., rises by the same absolute or proportional amount that
it otherwise would in the absence of feeding, then any poten-
tial source of error has been substantially ameliorated by the
design.
The problem in this instance would be amplified if there
was an interaction between the altered baseline and task. If the
response is attenuated or amplified, i.e., there is an interaction
between the task effect and the source of artifact, then the sit-
uation is concerning, doubly so if a small sample is being used.
To a small sample with normative values (e.g., Nunan et al.,
2010; LF = 519ms2, HF = 657ms2), a mean increase in HF ms2
subsequent to drinking (Routledge et al., 2002; HF +686ms2)
has the potential to destroy the fidelity of an entire measure-
ment at baseline. If this change interacts with any given task-
related effect, the sample quickly runs the risk of becoming
uninterpretable.
NORMALIZED AND LF/HF VARIABLES; CO-REPORTING AND
EQUIVALENCE
Co-reporting of equivalent ratio values is reasonably common,
observed in over half (59%) of the studies which employed nor-
malized units or LF/HF. The definition of these measures as
redundant is borne out by the results. The argument might
be made that this is not problematic, as HRV studies typically
employ a range of time and frequency domainmeasures which are
multicollinear. This is impossible to avoid, as most HRVmethods
some manner of apportioning a meaning to some quantity of the
available variance in a heart period series, and cross from time to
frequency domain readily as the integral of the total power spec-
trum is equal to the variance. These interrelationships are often
very high—Massin et al. (1999) report, for example, that RMSSD,
pNN50 and HF power are mutually correlated above 0.9.
However, there are several problems with this line of argument
when applied to multiple ratio measures. It is generally accepted
that multiple similar measures of HRV might be employed to the
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FIGURE 10 | The relationship of mean ratios to approximate mean
normalized values, where (A) LF r2 = 0.363; (B) HF r2 = 0.685, n = 20.
The dashed lines represent the mathematical identities as previously
defined.
same end to address the same phenomenon may differ slightly—
for example, in a group undergoing an experimental intervention,
RMSSD may be significantly increased by task and HF power
not. Were this the case, the result would be taken as equivocal
support for a change in cardiac vagal modulation, and the differ-
ence in the result between the similar calculatory methods would
be addressed. Alternatively, if LFnu was significant and LF/HF
not, this might be interpreted as a change in relative sympathetic
activity, but no change in sympathovagal balance. Secondly, other
measures which may be closely correlated attempt to measure the
FIGURE 11 | Relative standard error (i.e., the standard error divided by
the mean, which forms the sample-sized adjusted coefficient of
variation) for LFnu (n = 29), HFnu (n = 30) and LF/HF (n = 30), shown
here by median, interquartile range and min/max.
same phenomenon but use entirely disparate methods. However,
normalized and ratio values are mathematically, not theoretically,
related. There is no equivalent transform which might imply, say,
an RMSSD value from a value of HF spectral power.
Thirdly, it is unclear which of the ratio measures best repre-
sents the comparison they are both attempting to capture. For
instance, normalized units are more likely to obey parametric
assumptions, but LF/HFmay exhibit significant skew and kurtosis
(Kobayashi et al., 2012). This is directly confirmed in Figure 11,
as the relative standard error of both normalized units is sub-
stantially lower than LF/HF. If the relationship is mathematically
equivalent, and we also accept a degree of measurement error,
how should we interpret an instance where one value is significant
and the other not? Is it inconsistent to report both if one works?
If a sample of LF/HF obeys standard parametric assumptions,
should it still be log-transformed?
Lastly, it is by no means uncommon for normalized spectral
bands and the LF/HF ratio to form the entirety of an analysis in
an attempt to measure relative sympathetic and parasympathetic
contributions, and their interrelationship. This is rarely the case
with other interrelated variables.
NORMALIZED VARIABLES AND UNITY
Overall, the predictions from the mathematical equivalence in
the introduction were borne out—the curvilinear relationship
between normalized and ratio figures were observed. In some
comparisons, however, slight to significant departure can be
seen contingent on normalized values adding to unity—this was
the case for a minority of studies observed, with 4 of the 34
observed sums of LFnu and HFnu below 90%. These departures
are reflected in Figure 9, and are marked as diamonds between all
graphs for continuity.
There are multiple, non-mutually exclusive possibilities for
this discontinuity which are not simply calculatory error. The first
is the use of an alternative definition of adjusted LF power, i.e.,
LF/(total power). As the contribution from VLF power is usually
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significant, this may explain the larger error but not the prepon-
derance of values from 95 to 99% of the sum LFnu + HFnu.
The second is that there are small but significant contributions
to spectral power above 0.4Hz, which are included in total power
but not included as part of the HF frequency band—this might
explain the frequent values close to 1, but not the significant devi-
ations from it. The third is confusion in the calculation of the
autoregressive method between the dominant power components
in each spectral band which frequently overlap into the other
segments, and the power spectral density of all components but
strictly within the defined power band.
This non-equivalence is responsible for the shift in the distri-
bution that can be seen in Figure 9—the bulk of the points are
distributed as expected, but lie rightwards of the line of defini-
tion, where the ratio value is slightly bigger than predicted. The
regression of the data conforms to this.
It cannot be concluded precisely what this difference repre-
sents. The best case scenario for the use of normalized units would
be that this difference is borne of the fact that the individual spec-
tral powers retain some statistical independence, and describe a
portion of the relevant variance in their spectral bands without
absolute covariation.
The worst case scenario is that this is simply a calculatory
curiosity which has no specific meaning, borne of the arbitrary
distinction between the whole spectral element (say, the power
under the peak which provides the bulk of LF power) and the
truncated version (say, the PSD from precisely 0.04 to 0.15Hz of
all components). If the “true” sum of LFnu and HFnu is always
1, then their statistical equivalence is complete—in comparisons,
the metrics they return for continuous or directional compari-
son (e.g., Spearman’s r, Student’s t) to other variables will differ
by sign, and F-values not at all. If this is the case, then this error
has previously allowed the precise equivalence of LFnu or HFnu
to be partially obscured, and normalized/ratio units substantially
obscured, by providing values which are somewhat divergent and
giving the appearance of independence.
DISPERSION OF RATIO VALUES
LF/HF ratio shows an obvious decrease in precision over either
normalized variables (Figure 11). This is likely due to the volatil-
ity of the LF/HF ratio during normal sympathetic dominance as
HF approaches zero, as recently suggested (Billman, 2013). Two
examples from the sample set reviewed demonstrate this potential
volatility. Muralikrishnan et al. (2012) report a range of auto-
nomic measures on Ishant Yoga practitioners vs. normal controls.
At supine rest, the normal sample was described thus: n = 14,
μ = 1.86, and SD = 6.35. As LF/HF ratio cannot be less than
zero, this sample must contain one or more participants with a
ratio of 15 or more, most likely due to HF power being minimal
(a common occurrence when breathing rates are slow; see Saboul
et al., 2014). As a consequence, the description of this sample by
mean and standard deviation is unintelligible, as the distribution
has profound positive skew.
Similarly, Chen et al. (2012) compared HRV metrics of resus-
citated cardiac arrest patients, patients with sepsis and healthy
controls. The raw LF and HF power of healthy controls ranged
between approximately 12–100 times greater than all patient
groups. For instance, post-cardiac arrest patients had both LF
and HF spectral power of approximately 5ms2, and healthy con-
trols approximately 100ms2. As a consequence, both of these
groups had a median LF/HF ratio of 1. Alternatively, a difference
was found between non-surviving (LF/HF = 0.2) and surviving
(LF/HF = 3.1) cardiac arrest patients. However, none of the four
spectral powers involved in this calculation had a median above
7.6ms2.
None of the values above defined by ratio would be meaning-
ful by themselves, and in the context of the original papers are
appropriately reported and interpreted with both measures of the
raw spectral power and total power. But as seen in Table 2, this is
not the case for approximately 30% of published work.
LIMITATIONS
There are several limitations to the present work, the most obvi-
ous of which is that it makes no attempt to propose a method
by which spectral power should be assessed. There are a pro-
found amount of variables to consider regarding such a question;
whether spectral assumptions are appropriate in the first instance,
which variant of spectral analysis is sufficient or optimal, how
heartbeat series should be interpolated (if at all), how the series
should be corrected (if at all) or windowed, and so forth.
On the same basis, this work records neither outcomes nor dif-
ferences between free and paced breathing, specific time of day of
recording, or participant age. The data set as reviewed is incapable
of sustaining the scale of such a meta-analysis—for instance,
Nunan et al. (2010) initially reviewed over 3000 individual pieces
of research to draw a sample of n = 44 in which different meth-
ods of spectral analysis and the values they return within LF and
HF bands could be compared, a requirement to meta-analytically
compare regular measures of HRV spectral power to normalized
or ratio variables. This relationship would almost certainly inter-
act with the use of HRV to predict, investigate or stratify clinical
conditions, as HRV values may be profoundly affected especially
by autonomic and circulatory diseases. As a consequence, this
work cannot speak to whether normalized or ratio units are capa-
ble of sustaining conclusions which are similar to those from raw
values. Regardless of the basis on which they are characterized,
or their internal consistency, or the manner of their usage, they
may still reliably report the same or similar conclusions to other
methods.
Finally, this work cannot determine the dispersion of values
over the time of day or lifespan, or any relationship between these
variables and themethodology used. This would be a worthy topic
of future investigation, as HRV is used differentially within par-
ticular fields which are defined by time or age at recording (for
instance, chronobiology or antenatal care), and the methodology
between them is rarely compared.
CONCLUSION
This review has concentrated on commonly used methodology,
and hence the internal and external consistency, for collecting
HRV by frequency analysis over the short term. In general, the
nature of commonly used HRV metrics are not well under-
stood, and these measurement are intimately related both on
a mathematical level and in practice. Regardless of this, they
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are frequently treated as independent concepts and deployed
redundantly. Additionally, insufficient attention is paid to the
environment of data collection. None of these are trivial concerns;
rather, they call into question the accuracy of the existing litera-
ture onHRV and warrant the re-establishment of an authoritative
source for correct methodology and practice.
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